Alzheimer's disease is the most common cause of dementia and continues to pose significant medical, social, and economic challenges worldwide. Ongoing research is essential for improving early diagnosis, treatment, and quality of life for affected individuals.
This track focuses on the pathology of Alzheimer's disease, cognitive decline, biomarkers, genetics, neuroimaging, clinical diagnosis, and emerging therapeutic interventions. Discussions will also cover other forms of dementia, including vascular dementia, Lewy body dementia, and frontotemporal dementia.
Attendees will explore innovative research, clinical trials, precision medicine approaches, and multidisciplinary care strategies that support patients, caregivers, and healthcare systems in managing dementia effectively.